Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells

被引：0
|
作者：
Claudia Dominici
Nicolas Sgarioto
Zhenbao Yu
Laura Sesma-Sanz
Jean-Yves Masson
Stéphane Richard
Noël J.-M. Raynal
机构：
[1] McGill University,Segal Cancer Center, Lady Davis Institute for Medical Research and Gerald Bronfman Department of Oncology and Departments of Biochemistry, Human Genetics and Medicine
[2] Université de Montréal,Département de Pharmacologie et Physiologie
[3] and Research Centre of the Sainte-Justine University Hospital,Genome Stability Laboratory, CHU de Québec Research Center, Oncology Division, Department of Molecular Biology, Medical Biochemistry and Pathology
[4] Laval University Cancer Research Center,undefined
来源：
Clinical Epigenetics | 2021年 / 13卷
关键词：
Type I PRMT inhibitors; PARP inhibitors; MTAP; Drug resistance; Synergy; Non-small cell lung cancer cells; DNA damage; And cytotoxic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors
    Deraska, Peter V.
    Reavis, Hunter D.
    Labe, Shelby
    D'Andrea, Alan D.
    Kozono, David
    CANCER RESEARCH, 2017, 77
  • [32] Emerging angiogenesis inhibitors for non-small cell lung cancer
    Malapelle, Umberto
    Rossi, Antonio
    EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (02) : 71 - 81
  • [33] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [34] RAF and MEK Inhibitors in Non-Small Cell Lung Cancer
    Adamopoulos, Christos
    Papavassiliou, Kostas A.
    Poulikakos, Poulikos I.
    Papavassiliou, Athanasios G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [35] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [36] BRAF inhibitors in metastatic non-small cell lung cancer
    Anguera, Georgia
    Majem, Margarita
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 589 - 592
  • [37] MEK inhibitors for the treatment of non-small cell lung cancer
    Jing Han
    Yang Liu
    Sen Yang
    Xuan Wu
    Hongle Li
    Qiming Wang
    Journal of Hematology & Oncology, 14
  • [38] New generation of cancer stem cells inhibitors in non-small cell lung cancer.
    Labrador, Hector Amado
    Aguilar-Gallardo, Cristobal
    Herreros-Pomares, Alejandro
    Munera-Maravilla, Ester
    Calabuig-Farinas, Silvia
    Escorihuela, Eva
    Murga, Juan
    Jantus-Lewintre, Eloisa
    Camps, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Thymidylate synthase inhibitors for non-small cell lung cancer
    Galvani, Elena
    Peters, Godefridus J.
    Giovannetti, Elisa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1343 - 1356
  • [40] MEK inhibitors for the treatment of non-small cell lung cancer
    Han, Jing
    Liu, Yang
    Yang, Sen
    Wu, Xuan
    Li, Hongle
    Wang, Qiming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
12345